Clinical Development,R&D,Bioprocess,Weekly Roundups

Weekly News Round-up – 7/8/20

Proventa International Weekly News 4 years ago By Josh Neil
Proventa International Weekly News

In the news this week, vaccine deals are afoot on either side of the Atlantic: both the U.K. and U.S. governments have signed deals with Sanofi and GSK for doses of their COVID-19 vaccine, while the UK has also requested pharma companies begin stockpiling drugs for the period immediately post-Brexit. In other news, more potential COVID drugs appear on the horizon, though the price for current candidates is seen to vary wildly between companies.

UK SIGNS COVID-19 VACCINE DEAL WITH GSK AND SANOFI – The UK government has signed a fourth deal on coronavirus vaccines, this time securing 60 million doses of an experimental treatment, The government also secured another 90 million doses of two other promising vaccines. The GSK/Sanofi vaccine is based on the recombinant protein-based technology Sanofi uses to produce a flu vaccine. Regulatory approval for the vaccine could be reached halfway through 2021, if all trials are successful. 

UK GOVERNMENT CALLS FOR POST-BREXIT DRUG STOCKPILES – The UK government has requested that pharma companies stockpile at least six weeks’ worth of drugs in readiness for the full Brexit transition. This reserve would, it said, provide a buffer against the disruption caused by COVID-19. 

U.S. GOVERNMENT SANOFI/GSK PAYS $2.1 BILLION FOR COVID VACCINE DOSES – The Trump administration has committed more than $2 billion for an initial 100 million doses of Sanofi/GSK’s potential COVID-19 vaccine. This comes as part of its Operation Warp Speed vaccine development initiative, and will accelerate manufacturing of the vaccine. 

In other news:

R&D
Gilead urged to study potential COVID-19 treatment showing promise in cats 

Clinical Trials
Eli Lilly’s COVID-19 antibody begins nursing home trials
Novavax COVID vaccine produces antibodies in early-stage trials

Manufacturing
Moderna and J&J have disclosed vastly different price points for their lead COVID-19 vaccine candidates
State attorneys request that U.S. lowers price of remdesivir

That’s all for now. See you next week!

Joshua Neil, Editor
Proventa International

To ensure you remain up-to-date on the latest in clinical development, sign up for Proventa International’s online Biomanufacturing Strategy Meeting 2020.

More news

Role of an Immunologist: Exploring the Responsibilities

In the intricate web of human health, the immune system stands as a vigilant guardian, tirelessly defending against potential threats. At the forefront of understanding, deciphering, and harnessing the immune system's power is the immunologist. This article delves into the...

1 year ago
Clinical Development,R&D,Bioprocess,Weekly Roundups

Role of an Immunologist: Exploring the Responsibilities

In the intricate web of human health, the immune system stands as a vigilant guardian, tirelessly defending against potential threats. At the forefront of understanding, deciphering, and harnessing the immune system's power is the immunologist. This article delves into the...

1 year ago

Improving Warehouse Efficiency: The Role of Technology and Best Practices

In the fast-paced world of supply chain management, warehouse efficiency plays a pivotal role in ensuring timely and accurate order fulfillment while minimizing costs. With the rising demands of e-commerce and globalization, businesses are continually seeking innovative ways to optimize...

1 year ago
Clinical Development,R&D,Bioprocess,Weekly Roundups

Improving Warehouse Efficiency: The Role of Technology and Best Practices

In the fast-paced world of supply chain management, warehouse efficiency plays a pivotal role in ensuring timely and accurate order fulfillment while minimizing costs. With the rising demands of e-commerce and globalization, businesses are continually seeking innovative ways to optimize...

1 year ago

How to Reduce the Cost of Clinical Trial Supply Chain While Maintaining Quality and Efficiency

Clinical trial supply chain is a critical component of drug development, ensuring that drugs are available for testing, regulatory approval, and distribution. However, managing this supply chain can be challenging, with factors such as cost, quality, and efficiency all coming...

2 years ago
Clinical Development,R&D,Bioprocess,Weekly Roundups

How to Reduce the Cost of Clinical Trial Supply Chain While Maintaining Quality and Efficiency

Clinical trial supply chain is a critical component of drug development, ensuring that drugs are available for testing, regulatory approval, and distribution. However, managing this supply chain can be challenging, with factors such as cost, quality, and efficiency all coming...

2 years ago